An optimised anti-cancer virus
ColoAd1 is a highly potent broad-spectrum anti-cancer therapeutic capable of destroying tumour cells at minute concentrations. It is a unique oncolytic virus developed using the evolutionary principle of natural selection to generate a virus with optimal anti-cancer properties.
Originally developed in collaboration with Bayer Schering, ColoAd1 is our lead candidate using the directed evolution process and is now in late pre-clinical development and is currently undergoing GMP scale up production.
More Info ยป